Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu

Alternatives · ranked for women

Alternatives to DoctorAdam

People usually look past DoctorAdam because it scores lowest on postpartum & breastfeeding guidance (18/100) in our rubric, and because no injectable option at all, which rules it out if you want the form most trial evidence is based on.

Where DoctorAdam is strongest
True monthly cost — 58/100
Semaglutide
$129/mo (starting rate)
Tirzepatide
$199/mo (starting rate)
Coverage
All 50 states

DoctorAdam lands at #237 on our ranking with a Metabolic-Fit Score of 35/100. If it isn't the right fit, here are the strongest alternatives for women's GLP-1 care — scored on the same women's-health rubric of PCOS suitability, clinical oversight, price, access, support and fair cancellation.

Our #1 pick for women

Ranked #1 · Grade A−

CoreAge Rx

One flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.

Semaglutide
$99/mo
Tirzepatide
$149/mo
Coverage
All 50 states
Brand-name
Compounded only

More alternatives, in ranking order

telos rx

Ranked #16 · Grade C

Four flat, posted price points across semaglutide and three tirzepatide formats, with a written promise the cost won't climb with your dose — a real step up in clarity from what we found last check — undercut by a state list it still won't publish.

  • $30/mo cheaper than DoctorAdam
  • scores 75/100 against DoctorAdam's 35

BeyondMD

Ranked #69 · Grade C

BeyondMD publishes its prices before intake and names eleven clinicians with real bios, both of which are uncommon — but 'Starting at $125' is the floor of a $139-to-$449 band that appears on exactly one page, plus a $34 consultation fee and unpriced shipping, and the number you would actually pay is quoted on a phone call because every GLP-1 button leads to a lead form rather than a cart. Its Terms of Service contain no refund policy, no cancellation policy and no auto-renewal terms at all — the word 'refund' does not appear once in 44 KB.

  • $4/mo cheaper than DoctorAdam
  • offers FDA-approved brand pens, not just compounded
  • scores 51/100 against DoctorAdam's 35

yourEra

Ranked #15 · Grade C

A low-entry, all-in compounded program with both molecules and a clean cancel-anytime policy — appealing if the starting price holds, but the ongoing rate isn't published and the outcome claims are unverified marketing.

  • $30/mo cheaper than DoctorAdam
  • scores 76/100 against DoctorAdam's 35

Shapely

Ranked #94 · Grade C

Shapely is the first provider in this batch that takes insurance — it says it is in network with Medicare and major PPO plans, and quotes brand-name co-pays of "typically $25 per month". That genuinely changes the arithmetic for anyone with coverage. What has to be read carefully is what the membership buys: $99 a month, $49 for the first, and it explicitly does not include medications or labs. So the compounded prices, $99 for semaglutide and $166 for tirzepatide, sit on top of the membership rather than replacing it.

  • $30/mo cheaper than DoctorAdam
  • offers FDA-approved brand pens, not just compounded
  • scores 50/100 against DoctorAdam's 35

PreventiveMD

Ranked #66 · Grade C

"As low as $83/mo, all-in" is $999 paid up front, divided by twelve. That is not an inference — the site's own code takes the cheapest tier's total, divides by its month count, and prints the smallest result it finds, and its price API returns $999 for the twelve-month semaglutide supply. Month to month is $119. The honest thing to say next is that $119 is still cheaper than most of this roster, so the problem is the advertised number rather than the price behind it.

  • $10/mo cheaper than DoctorAdam
  • offers FDA-approved brand pens, not just compounded
  • scores 52/100 against DoctorAdam's 35

Strut Health

Ranked #9 · Grade B−

Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.

  • scores 80/100 against DoctorAdam's 35

ShedRx

Ranked #13 · Grade C

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

  • offers FDA-approved brand pens, not just compounded
  • scores 76/100 against DoctorAdam's 35

SynergyRX

Ranked #14 · Grade C

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

  • offers FDA-approved brand pens, not just compounded
  • scores 76/100 against DoctorAdam's 35

Pepti

Ranked #33 · Grade C

Pepti publishes the lowest semaglutide price in this entire roster — $99 a month, flat at every titration dose, with the medication, physician review, shipping, refill management and unlimited messaging with your prescribing doctor all inside it. Tirzepatide is $199 on the same all-in, flat-at-every-dose basis. That number is low enough to deserve skepticism, so it is worth saying exactly where it comes from: Pepti states it on a dedicated cost page, repeats it in its FAQ ('we keep pricing flat and transparent at $99/mo all-in'), and prices the comparison against Hims, Henry Meds and Mochi on the same page. It names two prescribing physicians and says its medication is compounded by FDA-registered 503A or 503B pharmacies, though it never names which. The real limits are reach and format: it ships to 36 states rather than 50, it is cash-pay only and bills no insurance, and its needle-free oral GLP-1/GIP drops cost $349 — well above its own injection.

  • $30/mo cheaper than DoctorAdam
  • scores 58/100 against DoctorAdam's 35

Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.

← All comparisons